<DOC>
	<DOCNO>NCT01990313</DOCNO>
	<brief_summary>The purpose study provide objective measurement abnormal movement body correlation neural activity brain track change time . This may allow development objective evaluation neural activity cause abnormal movement , may lead ability DBS system stimulate brain sense abnormal neural activity cause abnormal movement .</brief_summary>
	<brief_title>Neural Signatures Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>diagnosis idiopathic Parkinson 's disease , bilateral symptom Hoehn Yahr Stage great equal II . Documented improvement motor sign versus dopaminergic medication , change Unified Parkinson 's Disease Rating Scale motor ( UPDRS III ) score &gt; = 30 % medication . The presence complication medication wear sign , fluctuate response and/or dyskinesia , and/or medication refractory tremor , and/or impairment quality life medication due factor . Subjects stable dos medication , remain unchanged DBS system activate . After DBS system optimize ( time overall medication dose may reduce avoid discomfort complication dyskinesias ) medication dose remain unchanged , possible , duration study . Treatment carbidopa/levodopa , dopamine agonist maximal tolerate dos determine movement disorder neurologist . Ability willingness return study visit , initial programming three , six twelve month DBS . Age &gt; 18 Subjects significant cognitive impairment and/or dementia determine standardized neuropsychological battery . Subjects clinically active depression , define accord Diagnostic Statistical manual Mental Disorders , Fourth Edition ( DSMIV ) criterion score validated depression assessment scale . Subjects advance Parkinson 's disease , Hoehn Yahr stage 5 medication ( nonambulatory ) . Age &gt; 80 . Subjects implant electronic device neurostimulator , cardiac pacemaker/defibrillator medication pump . Subjects , pregnant , capable become pregnant , breast feeding . Patients cortical atrophy proportion age focal brain lesion could indicate nonidiopathic movement disorder determine MRI Subjects major comorbidity increase risk surgery ( prior stroke , severe hypertension , severe diabetes , need chronic anticoagulation aspirin ) . Subjects prior intracranial surgery . Subjects history seizure . Subjects , immunocompromised . Subjects active infection . Subjects , require diathermy , electroconvulsive therapy ( ECT ) , transcranial magnetic stimulation ( TMS ) treat chronic condition . Subjects , inability comply study followup visit . Subjects , unable understand sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>DBS</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>Subthalamic Nucleus</keyword>
</DOC>